Some studies measured PD-L1 in the tumor, some measure PD-L1 in immune-infiltrating cells, and some measure both, all with different PD-L1 antibodies (SP142, 22C3, 28–8, and 5H1). This evidence concerns the gene CD274 and neoplasm.